Deoxynybomycin is a selective anti-tumor agent, inducing apoptosis and inhibiting topoisomerase I. References: Richter MF, Drown BS, Riley AP, Garcia A, Shirai T, Svec RL, Hergenrother PJ. Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature. 2017 May 10. doi: 10.1038/nature22308. [Epub ahead of print] PubMed PMID: 28489819.

纯度：≥98%

CAS：27259-98-9